Matches in SemOpenAlex for { <https://semopenalex.org/work/W2968275875> ?p ?o ?g. }
Showing items 1 to 92 of
92
with 100 items per page.
- W2968275875 abstract "Abstract BACKGROUND: Due to the lack of specificity of contrast-enhanced (CE) MRI, both the response assessment and differentiation of progression from pseudoprogression (PsP) following immunotherapy using checkpoint inhibitors (ICI) or targeted therapy (TT) may be challenging, especially when ICI or TT is applied in combination with radiotherapy (RT). Here, we evaluated the value of amino acid PET using O-(2-[18F]fluoroethyl)-L-tyrosine (FET) as a problem-solving tool in comparison to CE-MRI in patients with brain metastases (BM) secondary to malignant melanoma (MM) and NSCLC. METHODS: We retrospectively identified 31 patients with 74 BM secondary to MM (n=20 with 42 BM) and NSCLC (n=11 with 32 BM) who underwent 52 FET-PET scans during the course of disease. All patients had RT prior to ICI or TT initiation (61%) or RT concurrent to ICI or TT (39%). In 13 patients, FET-PET was performed for treatment response assessment of ICI or TT using baseline and follow-up scans (median time between scans, 4.2 months). In the remaining 18 patients, FET-PET was used for the differentiation of progression from PsP related to RT plus ICI or TT. In all BM, metabolic activity on FET-PET was evaluated by calculation of tumor/brain ratios. FET-PET imaging findings were compared to CE-MRI and correlated to the clinical follow-up or neuropathological findings after neuroimaging. RESULTS: In 4 of 13 patients (31%), FET-PET provided additional information for treatment response evaluation beyond the information provided by CE-MRI alone. Furthermore, responding patients on FET-PET had a median stable clinical follow-up of 10 months. In 10 of 18 patients (56%) with CE-MRI findings suggesting progression, FET-PET detected PsP. In 9 of these 10 patients, PsP was confirmed by a median stable clinical follow-up of 11 months. CONCLUSIONS: FET-PET may add valuable information for treatment monitoring in individual BM patients undergoing RT in combination with ICI or TT." @default.
- W2968275875 created "2019-08-22" @default.
- W2968275875 creator A5007603481 @default.
- W2968275875 creator A5008568372 @default.
- W2968275875 creator A5013385281 @default.
- W2968275875 creator A5027997478 @default.
- W2968275875 creator A5031985321 @default.
- W2968275875 creator A5036157197 @default.
- W2968275875 creator A5039453752 @default.
- W2968275875 creator A5042462004 @default.
- W2968275875 creator A5046936224 @default.
- W2968275875 creator A5047435894 @default.
- W2968275875 creator A5048404962 @default.
- W2968275875 creator A5061611407 @default.
- W2968275875 creator A5068510584 @default.
- W2968275875 creator A5068698535 @default.
- W2968275875 creator A5081489767 @default.
- W2968275875 creator A5087050668 @default.
- W2968275875 creator A5088140147 @default.
- W2968275875 creator A5091809961 @default.
- W2968275875 date "2019-08-01" @default.
- W2968275875 modified "2023-09-23" @default.
- W2968275875 title "OTHR-14. TREATMENT MONITORING OF IMMUNOTHERAPY AND TARGETED THERAPY USING FET PET IN PATIENTS WITH MELANOMA AND LUNG CANCER BRAIN METASTASES: INITIAL EXPERIENCES" @default.
- W2968275875 doi "https://doi.org/10.1093/noajnl/vdz014.091" @default.
- W2968275875 hasPublicationYear "2019" @default.
- W2968275875 type Work @default.
- W2968275875 sameAs 2968275875 @default.
- W2968275875 citedByCount "0" @default.
- W2968275875 crossrefType "journal-article" @default.
- W2968275875 hasAuthorship W2968275875A5007603481 @default.
- W2968275875 hasAuthorship W2968275875A5008568372 @default.
- W2968275875 hasAuthorship W2968275875A5013385281 @default.
- W2968275875 hasAuthorship W2968275875A5027997478 @default.
- W2968275875 hasAuthorship W2968275875A5031985321 @default.
- W2968275875 hasAuthorship W2968275875A5036157197 @default.
- W2968275875 hasAuthorship W2968275875A5039453752 @default.
- W2968275875 hasAuthorship W2968275875A5042462004 @default.
- W2968275875 hasAuthorship W2968275875A5046936224 @default.
- W2968275875 hasAuthorship W2968275875A5047435894 @default.
- W2968275875 hasAuthorship W2968275875A5048404962 @default.
- W2968275875 hasAuthorship W2968275875A5061611407 @default.
- W2968275875 hasAuthorship W2968275875A5068510584 @default.
- W2968275875 hasAuthorship W2968275875A5068698535 @default.
- W2968275875 hasAuthorship W2968275875A5081489767 @default.
- W2968275875 hasAuthorship W2968275875A5087050668 @default.
- W2968275875 hasAuthorship W2968275875A5088140147 @default.
- W2968275875 hasAuthorship W2968275875A5091809961 @default.
- W2968275875 hasBestOaLocation W29682758751 @default.
- W2968275875 hasConcept C121608353 @default.
- W2968275875 hasConcept C126322002 @default.
- W2968275875 hasConcept C143998085 @default.
- W2968275875 hasConcept C2776256026 @default.
- W2968275875 hasConcept C2777658100 @default.
- W2968275875 hasConcept C2777701055 @default.
- W2968275875 hasConcept C502942594 @default.
- W2968275875 hasConcept C71924100 @default.
- W2968275875 hasConceptScore W2968275875C121608353 @default.
- W2968275875 hasConceptScore W2968275875C126322002 @default.
- W2968275875 hasConceptScore W2968275875C143998085 @default.
- W2968275875 hasConceptScore W2968275875C2776256026 @default.
- W2968275875 hasConceptScore W2968275875C2777658100 @default.
- W2968275875 hasConceptScore W2968275875C2777701055 @default.
- W2968275875 hasConceptScore W2968275875C502942594 @default.
- W2968275875 hasConceptScore W2968275875C71924100 @default.
- W2968275875 hasLocation W29682758751 @default.
- W2968275875 hasLocation W29682758752 @default.
- W2968275875 hasOpenAccess W2968275875 @default.
- W2968275875 hasPrimaryLocation W29682758751 @default.
- W2968275875 hasRelatedWork W1536491945 @default.
- W2968275875 hasRelatedWork W2023349936 @default.
- W2968275875 hasRelatedWork W2299628688 @default.
- W2968275875 hasRelatedWork W2392381781 @default.
- W2968275875 hasRelatedWork W2509771080 @default.
- W2968275875 hasRelatedWork W2521186644 @default.
- W2968275875 hasRelatedWork W2890495962 @default.
- W2968275875 hasRelatedWork W289749372 @default.
- W2968275875 hasRelatedWork W2900090871 @default.
- W2968275875 hasRelatedWork W2938657684 @default.
- W2968275875 hasRelatedWork W2967308861 @default.
- W2968275875 hasRelatedWork W2968658229 @default.
- W2968275875 hasRelatedWork W2985069408 @default.
- W2968275875 hasRelatedWork W2986141571 @default.
- W2968275875 hasRelatedWork W2986904027 @default.
- W2968275875 hasRelatedWork W2994923067 @default.
- W2968275875 hasRelatedWork W3046995916 @default.
- W2968275875 hasRelatedWork W3047285635 @default.
- W2968275875 hasRelatedWork W3093054757 @default.
- W2968275875 hasRelatedWork W2741875405 @default.
- W2968275875 isParatext "false" @default.
- W2968275875 isRetracted "false" @default.
- W2968275875 magId "2968275875" @default.
- W2968275875 workType "article" @default.